Fig. 4From: Comparison of the diagnostic performance of twelve noninvasive scores of metabolic dysfunction-associated fatty liver diseaseThe Clinical utility of the indices were evaluated by decision curves in the NHANES cohort (A) and Western China cohort (B). The x-axis measures the threshold probability. The y-axis represents net benefits , calculated by subtracting the relative harms (false positive) from the benefits (true positives)Back to article page